💉 Lucknow sees dengue vaccine hype after India approval
The approval of Takeda’s QDENGA, India's first dengue vaccine, has caused a big spike in patient inquiries across Lucknow. Healthcare providers in Lucknow are now getting around 50 daily questions regarding its availability, eligibility, dosage, and cost. The Drug Controller General of India granted market authorization for ages 4-60, with a commercial rollout expected later this quarter. Studies indicate the vaccine has about 91% efficacy and protection lasting two to three years. Doctors advise that vaccination must supplement mosquito control measures rather than replace them.